Michael Ringenberg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Critical Path Institute (C-Path) today announced that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and Research (CDER) in the U.S. Food and Drug Administration (FDA) issued a Biomarker Letter of Support (LOS) for four pancreatic injury safety biomarkers identified and evaluated by C-Path's Predictive Safety Testing Consortium's (PSTC) Pancreatic Injury Working Group (PIWG).

United States Air Force Begins Construction on $403 Million Energy Savings Performance Contract with Schneider Electric to Enhance Mission Readiness at Yokota Air Base - Long-term solution improves energy infrastructure at the base through a combined heat and power plant with microgrid controls and energy efficiency to ensure reliable, resilient power supply - One of the most comprehensive resilience solutions within an ESPC to date by Department of Defense providing reduced and stabilized utility costs, power reliability, guaranteed uptime, operational continuity, and long-term onsite suppor...